FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2090803587> ?p ?o ?g. }

• W2090803587 endingPage "118" @default.
• W2090803587 startingPage "111" @default.
• W2090803587 abstract "INTRODUCTION AND OBJECTIVE: The aim of the present study is the immunohistochemical assessment of tumor progression markers (E-cadherin, β-catenin, CEACAM-1 and PTEN) in primary cutaneous melanomas and their correlation with prognostic factors. METHOD: Primary lesions in patients with cutaneous melanoma were recorded as to clinical data (age, gender, location and metastases) and anatomopathologic data (Breslow, Clark level, margins, histological type, mitosis, ulceration, regression, satellitosis and TIL type). It was made a comparison between immunohistochemical expression of the markers and prognostic and anatomopathologic factors. RESULTS: Breslow thickness was > 1 mm (thick) in 21 patients (48.83%) and < 1 mm (thin) in 22 (51.16%). There was a higher CEACAM-1 positive expression in thick melanomas than in thin ones (p = 0.002). There was a more frequent E-cadherin (p = 0.008), b-catenin (p = 0.001) and PTEN (p = 0.005) positive expression in thin melanomas than in thick ones. There was a more frequent CEACAM-1 positive expression in superficial (p = 0.003) and deep (p = 0.002) samples of thick melanomas than in thin ones. No statistically significant differences between clinical and histopathological data were found when comparing patients with (n = 6) and without metastasis (n = 15). DISCUSSION AND CONCLUSION: There was a higher positivity for E-cadherin, b-catenin and PTEN in thin melanomas, whereas there was a higher positivity for CEACAM-1 in thick melanomas." @default.
• W2090803587 created "2016-06-24" @default.
• W2090803587 creator A5014959949 @default.
• W2090803587 creator A5020716013 @default.
• W2090803587 creator A5025913767 @default.
• W2090803587 creator A5030184646 @default.
• W2090803587 creator A5042003308 @default.
• W2090803587 creator A5047581662 @default.
• W2090803587 creator A5084312073 @default.
• W2090803587 creator A5088695969 @default.
• W2090803587 date "2010-04-01" @default.
• W2090803587 modified "2023-09-23" @default.
• W2090803587 title "Immunohistochemical assessment of E-cadherin, β-catenin, CEACAM-1 and PTEN: tumor progression markers in melanoma" @default.
• W2090803587 cites W1528955439 @default.
• W2090803587 cites W1951046932 @default.
• W2090803587 cites W1975896984 @default.
• W2090803587 cites W1981662593 @default.
• W2090803587 cites W1999146832 @default.
• W2090803587 cites W2000749236 @default.
• W2090803587 cites W2005230990 @default.
• W2090803587 cites W2005312838 @default.
• W2090803587 cites W2022983845 @default.
• W2090803587 cites W2028125222 @default.
• W2090803587 cites W2065701510 @default.
• W2090803587 cites W2078197336 @default.
• W2090803587 cites W2079818771 @default.
• W2090803587 cites W2083574998 @default.
• W2090803587 cites W2096835115 @default.
• W2090803587 cites W2097051847 @default.
• W2090803587 cites W2097674943 @default.
• W2090803587 cites W2127120957 @default.
• W2090803587 cites W2148723211 @default.
• W2090803587 cites W2151876618 @default.
• W2090803587 cites W2157159356 @default.
• W2090803587 cites W2172053587 @default.
• W2090803587 cites W2182467204 @default.
• W2090803587 cites W79962957 @default.
• W2090803587 doi "https://doi.org/10.1590/s1676-24442010000200007" @default.
• W2090803587 hasPublicationYear "2010" @default.
• W2090803587 type Work @default.
• W2090803587 sameAs 2090803587 @default.
• W2090803587 citedByCount "5" @default.
• W2090803587 countsByYear W20908035872015 @default.
• W2090803587 countsByYear W20908035872016 @default.
• W2090803587 countsByYear W20908035872017 @default.
• W2090803587 countsByYear W20908035872020 @default.
• W2090803587 countsByYear W20908035872021 @default.
• W2090803587 crossrefType "journal-article" @default.
• W2090803587 hasAuthorship W2090803587A5014959949 @default.
• W2090803587 hasAuthorship W2090803587A5020716013 @default.
• W2090803587 hasAuthorship W2090803587A5025913767 @default.
• W2090803587 hasAuthorship W2090803587A5030184646 @default.
• W2090803587 hasAuthorship W2090803587A5042003308 @default.
• W2090803587 hasAuthorship W2090803587A5047581662 @default.
• W2090803587 hasAuthorship W2090803587A5084312073 @default.
• W2090803587 hasAuthorship W2090803587A5088695969 @default.
• W2090803587 hasBestOaLocation W20908035871 @default.
• W2090803587 hasConcept C104317684 @default.
• W2090803587 hasConcept C121608353 @default.
• W2090803587 hasConcept C126322002 @default.
• W2090803587 hasConcept C137620995 @default.
• W2090803587 hasConcept C142724271 @default.
• W2090803587 hasConcept C190283241 @default.
• W2090803587 hasConcept C204232928 @default.
• W2090803587 hasConcept C2777609662 @default.
• W2090803587 hasConcept C2777658100 @default.
• W2090803587 hasConcept C2779013556 @default.
• W2090803587 hasConcept C2780212769 @default.
• W2090803587 hasConcept C2908643394 @default.
• W2090803587 hasConcept C30145163 @default.
• W2090803587 hasConcept C502942594 @default.
• W2090803587 hasConcept C530470458 @default.
• W2090803587 hasConcept C55493867 @default.
• W2090803587 hasConcept C71924100 @default.
• W2090803587 hasConcept C86554907 @default.
• W2090803587 hasConcept C86803240 @default.
• W2090803587 hasConceptScore W2090803587C104317684 @default.
• W2090803587 hasConceptScore W2090803587C121608353 @default.
• W2090803587 hasConceptScore W2090803587C126322002 @default.
• W2090803587 hasConceptScore W2090803587C137620995 @default.
• W2090803587 hasConceptScore W2090803587C142724271 @default.
• W2090803587 hasConceptScore W2090803587C190283241 @default.
• W2090803587 hasConceptScore W2090803587C204232928 @default.
• W2090803587 hasConceptScore W2090803587C2777609662 @default.
• W2090803587 hasConceptScore W2090803587C2777658100 @default.
• W2090803587 hasConceptScore W2090803587C2779013556 @default.
• W2090803587 hasConceptScore W2090803587C2780212769 @default.
• W2090803587 hasConceptScore W2090803587C2908643394 @default.
• W2090803587 hasConceptScore W2090803587C30145163 @default.
• W2090803587 hasConceptScore W2090803587C502942594 @default.
• W2090803587 hasConceptScore W2090803587C530470458 @default.
• W2090803587 hasConceptScore W2090803587C55493867 @default.
• W2090803587 hasConceptScore W2090803587C71924100 @default.
• W2090803587 hasConceptScore W2090803587C86554907 @default.
• W2090803587 hasConceptScore W2090803587C86803240 @default.
• W2090803587 hasIssue "2" @default.
• W2090803587 hasLocation W20908035871 @default.
• W2090803587 hasLocation W20908035872 @default.

• next